This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of California. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Man-Tzu Wang: Innovator in Cancer Treatment
Introduction
Man-Tzu Wang is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer treatment, particularly in targeting K-Ras-mediated signaling pathways. Her innovative approach aims to provide new therapeutic options for patients suffering from K-Ras-expressing cancers.
Latest Patents
Wang holds a patent for her invention titled "Targeting K-Ras-mediated signaling pathways and malignancy by prostratin." This patent outlines a method for treating K-Ras-expressing cancer in a subject by administering a therapeutic amount of prostratin or a prostratin analog, along with compositions and kits designed for this purpose. She has 1 patent to her name, showcasing her commitment to advancing cancer therapies.
Career Highlights
Wang is affiliated with the University of California, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to change the landscape of cancer therapy, particularly for those with K-Ras mutations.
Collaborations
Wang collaborates with Frank McCormick, a notable figure in cancer research. Their partnership enhances the development of effective treatments and contributes to the scientific community's understanding of cancer biology.
Conclusion
Man-Tzu Wang's contributions to cancer treatment through her innovative patent demonstrate her dedication to improving patient outcomes. Her work at the University of California and collaboration with esteemed colleagues highlight her role as a leading inventor in the field.